fbpx

Episode 2

PEDs

Jun 22, 2020 | 0 comments

Ted, Javair, and Pat are joined by Dr. Bob Murray to discuss performance enhancing drugs/substances. Covering the gamut from legal to illegal, what’s been proven to work versus what doesn’t have the science to back it up, and everything in between, there are few mainstream substances that weren’t discussed in this episode. 

Notable Time Stamps

00:00 Introductions
03:10 Definitions around PEDs
04:58 Supplement Contamination
16:08 What Does Work (and is legal)
18:56 HGH
23:28 Post-Workout Recovery
27:27 Pre-Competition Workouts & Supplements
34:48 Creatine
38:03 Sodium Bicarbonate
39:44 Beet Juice
41:20 Joint Health
45:16 Game Day Meals
49:35 Substances Most Likely to Contain Banned Substances
57:21 Sleep, Hydration and Alcohol
1:01:52 Ancestry Testing, Blood Typing, Body Typing & Nutrition
1:03:30 Training the Brain/Nervous System
1:05:05 Injuries and Nutrition/Supplements
1:07:07 Return to Play Hydration
1:08:47 Ideal Routine for Athletes
1:13:33 What’s New and Upcoming

Related Episodes

Episode 46: Dr. Mann, Sandoval, Battley

Episode 46: Dr. Mann, Sandoval, Battley

Episode 46 Dr. Bryan Mann, Bo Sandoval, & Scott BattleyToday's episode of the Research 2 Reps Round table exemplifies the podcast's namesake. We're hosting Dr. Bryan Mann (Clinical Associate Professor of Kinesiology), Bo Sandoval (Assistant Athletics Director of...

Episode 45: Daniel Martinez

Episode 45: Daniel Martinez

Episode 45 Daniel MartinezWe started this Research 2 Reps Roundtable episode with an update of what we're each working on and that led us fluidly into the work of our guest, Daniel Martinez, of Trinity University. Our conversation went to the "deep" stuff fast with a...

Episode 44: Andrew Stuart

Episode 44: Andrew Stuart

Episode 44 Andrew StuartIn this episode of Research to Reps Roundtable, we welcome Andrew Stewart, the assistant director at the Nebraska Athletics Performance Lab (University of Nebraska). We cover everything from Andrew's diverse background in college football to...

0 Comments